
China Expands Medical Insurance to Enhance Coverage and Accessibility
China boosts its basic medical insurance by expanding drug catalogs, reducing medicine prices, and adding more services, enhancing coverage and accessibility.
My Global News: Voices of a New Era
๐ Stay Ahead, Stay Global ๐
China boosts its basic medical insurance by expanding drug catalogs, reducing medicine prices, and adding more services, enhancing coverage and accessibility.
China adds 13 rare-disease drugs to its medical insurance catalog, expanding coverage to over 90 medicines. This move aims to make treatment more accessible and affordable for patients nationwide.
China’s drug price negotiations have saved patients over $112 billion, enhancing access to 3,159 medications and improving coverage for chronic, rare, and pediatric diseases.
China’s national medical insurance list now includes 91 new drugs, reducing patient costs by 63% on average. The update enhances coverage for chronic, rare diseases and pediatric medications, effective January 2025.
A 2023 report highlights significant improvements in Chinaโs medical insurance system, enhancing service accessibility and ensuring fund sustainability with expanded coverage and reduced medical expenses.